Algodystrophy

Algodystrophy is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under: Musculoskeletal and Connective Tissue Diseases
Nervous System Diseases
Signs, Symptoms, and General Pathologies
Wounds and Injuries
Indicated drugs: Neridronic Acid

Resolves to

Vocabularies

MeSHM0328368ICD-10G90.5SNOMED CT128079007MedDRA10038249UMLSC0034931

What you can answer from here — as of November 01, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

1Clinical trialPhase, status and sponsor resolved per trial

Which approved drugs for Algodystrophy share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.